Therapeutic effect of gefin, a new antiviral drug, in experimental genital herpes
Alimbarova, L.M.; Barinskiĭ, I.F.; Kuz'min, K.K.
Voprosy Virusologii 47(1): 34-37
2002
ISSN/ISBN: 0507-4088 PMID: 11852781 Document Number: 545393
Antiviral activity of Gefin was studied in guinea pigs infected with herpes simplex virus (HSV-2). Up to 54.9% animals challenged with HSV survived after 7-day treatment with Gefin (3 local applications a day). The prospects of further trials of the drug in HSV genital herpes are discussed.
Document emailed within 1 workday
Related Documents
Yoosook, C.; Chantratita, W.; Rimdusit, P. 1989: Recovery frequencies of herpes simplex virus types 1 and 2 from symptomatic and asymptomatic genital herpes cases and antiviral sensitivities of isolates Journal of the Medical Association of Thailand 72(10): 572-576Meylan, P. 2005: Recommandations suisses pour le traitement de l'herpès génital et de l'herpès du nouveau-né - Swiss recommendations for the management of genital herpes and herpes simplex virus infection of the neonate Revue Medicale Suisse 1(36): 2315-2326
Wald, A.; Corey, L. 1999: Antiviral therapies for long-term suppression of genital herpes JAMA 281(13): 1169-70; author reply 1170-1
Jefferson, J.W. 1999: Antiviral therapies for long-term suppression of genital herpes JAMA 281(13): 1170-1171
Alimbarova, L.M.; Barinskiĭ, I.F.; Kuz'min, K.K. 1998: Evaluation of antiviral activity of new medicinal forms of foscarnet in genital herpes in guinea pigs Voprosy Virusologii 43(2): 82-86
Vestergaard, B.F. 1982: A prospective study of the relationship between genital herpes and carcinoma of the uterine cervix. I. Seroepidemiology of herpes simplex virus type 1 and type 2 in women with a previous history of clinically diagnosed genital herpes Developments in Biological Standardization 52: 95-98
1985: Estudo sobre a incidência de herpes genital feminino em Belém-Pará - Etude de l'incidence de l'herpès génital féminin à Belem-Para - Study of the frequency of genital herpes in women in Belem-Pará Boletim Epidemiologico (1969) 17(17-18): 129-135
2011: Aciclovir + hydrocortisone. Herpes labialis: a topical antiviral drug perhaps, but not a steroid Prescrire International 20(119): 205-207
Kushch, A.A.; Galegov, G.A.; Klimova, R.R.; Kozlov, A.I.; Litvin, A.A. 2008: Investigation of antiviral properties of new formulations of Panavir in the treatment of experimental herpes virus infection in mice Antibiotiki i Khimioterapiia 53(7-8): 31-34
Mel'nikov, V.R.; Kobrinskiĭ, G.D.; L'vov, N.D.; Bolotin, I.M.; Barinskiĭ, I.F. 1990: Treatment of experimental genital herpes with liposomal interferon Vestnik Akademii Meditsinskikh Nauk SSSR 8: 35-37
Kozulitsyna, T.I.; Uvarova, O.A.; Golyshevskaia, V.I.; El'shanskaia, M.P. 1980: Experimental study of therapeutic effect of various antibacterial drug combinations Problemy Tuberkuleza 7: 49-53
Mel'nikov, V.R.; Kobrinskiĭ, G.D.; Lidak, M.I.; Barinskiĭ, I.F. 1993: The combined treatment of experimental genital herpes with preparations of interferon and acycloguanosine administered systemically and locally Voprosy Virusologii 38(2): 69-71
Todd, J.; Riedner, G.; Maboko, L.; Hoelscher, M.; Weiss, H.A.; Lyamuya, E.; Mabey, D.; Rusizoka, M.; Belec, L.; Hayes, R. 2013: Effect of Genital Herpes on Cervicovaginal HIV Shedding in Women Co-Infected with HIV and Hsv-2 in Tanzania Plos one 8(3): E59037
Slomka, M.J. 1996: Seroepidemiology and control of genital herpes: the value of type specific antibodies to herpes simplex virus Communicable Disease Report. Cdr Review 6(3): R41-R45
Scoular, A.; Leask, B.G.; Carrington, D. 1990: Changing trends in genital herpes due to Herpes simplex virus type 1 in Glasgow, 1985-88 Genitourinary Medicine 66(3): 226
Jones, C.A.; Cunningham, A.L. 2004: Vaccination strategies to prevent genital herpes and neonatal herpes simplex virus (HSV) disease Herpes: the Journal of the Ihmf 11(1): 12-17
Kruglova, A.I.; Nikolaeva, N.P.; Niukhalova, I.V.; Barinskiĭ, I.F.; Alimbarova, L.M.; Demkin, V.V. 2004: Polymorphism of herpes simplex virus type 1 and 2 DNA from laboratory strains and clinical material from patient with genital herpes Voprosy Virusologii 49(1): 23-27
Karpovich, L.G.; Blokha, V.V.; Kalashnikova, T.V.; Bychkova, A.A.; Semenova, T.B. 1986: Indices of lymphocyte functional activity in patients with recurrent cutaneous-genital herpes during treatment with a herpes vaccine Voprosy Virusologii 31(2): 200-205
Kantakamalakul, W.; Naksawat, P.; Kanyok, R.; Puthavathana, P. 1999: Prevalence of type specific Epstein-Barr virus in the genital tract of genital herpes suspected patients Journal of the Medical Association of Thailand 82(3): 263-267
Rana, R.K.; Pimenta, J.M.; Rosenberg, D.M.; Tyring, S.K.; Paavonen, J.; Cook, S.F.; Robinson, N.J. 2005: Demographic, behavioral, and knowledge factors associated with herpes simplex virus type 2 infection among men whose current female partner has genital herpes Sexually Transmitted Diseases 32(5): 308-313